Stock GALT GALECTIN THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Galectin Therapeutics Inc.

Equities

GALT

US3632252025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.45 USD -1.43% Intraday chart for Galectin Therapeutics Inc. +2.37% +107.83%
Mar. 29 Galectin Therapeutics Inc. Appoints Benjamin S. Carson as Member of the Board of Directors CI
Mar. 29 Galectin Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Galectin Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

58c12700.p-DiOcJBNE_nY47nV-8gaYwa3lHfiSj1wZCDygnqUDQ.yLayf4cQQTadUumlMoZEEOtxtyTuxEyT7Niu8kvHGW7Sl5VgkXhfLKVa-Q~586d54e6f253b1d5e8d0e519d955672e

Analyst Recommendations on Galectin Therapeutics Inc.

HC Wainwright Adjusts Price Target on Galectin Therapeutics to $11 From $14, Reiterates Buy Rating MT
GALECTIN THERAPEUTICS : HC Wainwright Adjusts Price Target on Galectin Therapeutics to $14 From $12, Maintains Buy Rating MT
Galectin Therapeutics to Present at Berenberg NASH Day in New York GL
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.45 USD
Average target price
11 USD
Spread / Average Target
+218.84%
High Price Target
11 USD
Spread / Highest target
+218.84%
Low Price Target
11 USD
Spread / Lowest Target
+218.84%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Galectin Therapeutics Inc.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GALT Stock
  4. Consensus Galectin Therapeutics Inc.